These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29187235)

  • 21. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
    Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
    Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.
    Cussenot O; Sighar K; Mohammed M; Hugonin S; Ondet V; Larre S; Lacave R; Roupret M; Cancel-Tassin G
    World J Urol; 2014 Apr; 32(2):551-7. PubMed ID: 24196429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract.
    Hyrsl L; Zavada J; Zavadova Z; Kawaciuk I; Vesely S; Skapa P
    Neoplasma; 2009; 56(4):298-302. PubMed ID: 19473055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.
    Vlahou A; Schellhammer PF; Mendrinos S; Patel K; Kondylis FI; Gong L; Nasim S; Wright GL
    Am J Pathol; 2001 Apr; 158(4):1491-502. PubMed ID: 11290567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential molecular marker for detecting transitional cell carcinoma.
    Chiu AW; Huang YL; Huan SK; Wang YC; Ju JP; Chen MF; Chou CK
    Urology; 2002 Jul; 60(1):181-5. PubMed ID: 12100959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
    Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
    Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
    Heicappell R; Schostak M; Müller M; Miller K
    Scand J Clin Lab Invest; 2000 Jul; 60(4):275-82. PubMed ID: 10943597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.
    Langner C; Ratschek M; Tsybrovskyy O; Schips L; Zigeuner R
    J Histochem Cytochem; 2003 Aug; 51(8):1097-9. PubMed ID: 12871991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.
    Padrão NA; Monteiro-Reis S; Torres-Ferreira J; Antunes L; Leça L; Montezuma D; Ramalho-Carvalho J; Dias PC; Monteiro P; Oliveira J; Henrique R; Jerónimo C
    Br J Cancer; 2017 Feb; 116(5):634-639. PubMed ID: 28081549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder.
    Heicappell R; Wettig IC; Schostak M; Müller M; Steiner U; Sauter T; Miller K
    Eur Urol; 1999 Jan; 35(1):81-7. PubMed ID: 9933798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells.
    Wang X; Gu Y; Zhang S; Li G; Liu T; Wang T; Qin H; Jiang B; Zhu L; Li Y; Lei H; Li M; Zhang Q; Yang R; Fang F; Guo H
    Cancer Med; 2020 Jan; 9(1):290-301. PubMed ID: 31709750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies.
    Ben-Dov IZ; Whalen VM; Goilav B; Max KE; Tuschl T
    PLoS One; 2016; 11(1):e0147249. PubMed ID: 26785265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma].
    Miyoshi Y; Matsuzaki J; Miura T
    Hinyokika Kiyo; 2001 Jun; 47(6):379-83. PubMed ID: 11496392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.
    Xi Z; LinLin M; Ye T
    J Clin Lab Anal; 2009; 23(6):357-61. PubMed ID: 19927341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma.
    Sheryka E; Wheeler MA; Hausladen DA; Weiss RM
    Urology; 2003 Jul; 62(1):162-6. PubMed ID: 12837459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH
    Yonsei Med J; 2001 Feb; 42(1):14-8. PubMed ID: 11293494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
    Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
    J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.